Preliminary results of a phase 2 clinical trial of Genz-112638 in patients with type I Gaucher disease

被引：0
|
作者：
Lukina, E. [1 ]
Watman, N. [2 ]
Arreguin, E. A.
Banikazemi, M. [3 ]
Iastrebner, M. [4 ]
Rosenbaum, H. [5 ]
Zimran, A. [6 ]
O'Brien, F.
Smith, S. E.
Puga, A. C.
Peterschmitt, J.
机构：
[1] Russian Acad Med Sci, Hematol Res Ctr, Moscow, Russia
[2] Hosp Ramos Mejia, Buenos Aires, DF, Argentina
[3] NYU, New York, NY USA
[4] Inst Argentino Diagnost & Tratamiento, Buenos Aires, DF, Argentina
[5] Ramban Med Ctr, Haifa, Israel
[6] Shaare Zedek Med Ctr, Jerusalem, Israel
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
450P
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [31] Improvements in skeletal manifestations in gaucher disease Type 1 patients receiving oral eliglustat during a phase 2 trial
    Kamath, Ravi
    Lukina, Elena
    Watman, Nora
    Dragosky, Marta
    Iastrebner, Marcelo
    Pastores, Gregory M.
    Arreguin, Elsa Avila
    Rosenbaum, Hanna
    Phillips, Mici
    Kaper, Mathilde
    Puga, Ana Cristina
    Peterschmitt, M. Judith
    Rosenthal, Daniel I.
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S23 - S23
  • [32] Oxidative stress parameters of Gaucher disease type I patients
    Mello, Alexandre Silva
    Garcia, Cristina Da Silva
    Machado, Fernanda De Souza
    Medeiros, Niara Da Silva
    Wohlenberg, Mariane Farias
    Marinho, Jessica Pereira
    Dani, Caroline
    Funchal, Claudia
    Coelho, Janice Carneiro
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 4 : 1 - 5
  • [33] A neurological symptom survey of patients with type I Gaucher disease
    Pastores, GM
    Barnett, NL
    Bathan, P
    Kolodny, EH
    JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (07) : 641 - 645
  • [34] PREVALENCE OF NEUROLOGICAL MANIFESTATIONS IN PATIENTS WITH GAUCHER DISEASE TYPE I
    Mendes, C. Curiati
    Rand, M. H.
    Micheletti, C.
    Vertemati, T.
    Martins, A. M.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 82 - 82
  • [35] Preliminary results of a phase I trial of antisense to BCL-2 in lymphoma
    Waters, J
    Webb, A
    Cunningham, D
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 123 - 123
  • [36] Adaptive deep brain stimulation in patients with Parkinson's disease: phase II clinical trial preliminary results
    Rosa, M.
    Arlotti, M.
    Marceglia, S.
    Ardolino, G.
    Cogiamanian, F.
    Di Fonzo, A.
    Rampini, P.
    Priori, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E285 - E285
  • [37] TYPE I GAUCHER'S DISEASE: CLINICAL, EVOLUTIVE AND THERAPEUTIC FEATURES
    Alpoim, M.
    Fernandes, A.
    Chaves, P.
    Cardoso, T.
    Ferreira, F.
    Guimaraes, J.
    HAEMATOLOGICA, 2013, 98 : 734 - 734
  • [38] Clinical and radiological evaluation of dentomaxillofacial involvement in Type I Gaucher disease
    Firdevs Aşantoğrol
    Hüseyin Dursun
    Emin Murat Canger
    Fahri Bayram
    Oral Radiology, 2022, 38 : 210 - 223
  • [39] Hypercoagulability in type I Gaucher disease; Association with clinical features.
    Rosenbaum, H
    Lanir, N
    Hoffman, R
    Tennenbaum, G
    Rowe, JM
    Brenner, B
    BLOOD, 2000, 96 (11) : 32B - 32B
  • [40] Clinical and radiological evaluation of dentomaxillofacial involvement in Type I Gaucher disease
    Asantogrol, Firdevs
    Dursun, Huseyin
    Canger, Emin Murat
    Bayram, Fahri
    ORAL RADIOLOGY, 2022, 38 (02) : 210 - 223
12345